INSERM, UMR915, l'Institut du Thorax, Nantes, France.
PLoS One. 2010 Feb 19;5(2):e9298. doi: 10.1371/journal.pone.0009298.
Loss-of-function mutations in SCN5A, the gene encoding Na(v)1.5 Na+ channel, are associated with inherited cardiac conduction defects and Brugada syndrome, which both exhibit variable phenotypic penetrance of conduction defects. We investigated the mechanisms of this heterogeneity in a mouse model with heterozygous targeted disruption of Scn5a (Scn5a(+/-) mice) and compared our results to those obtained in patients with loss-of-function mutations in SCN5A.
METHODOLOGY/PRINCIPAL FINDINGS: Based on ECG, 10-week-old Scn5a(+/-) mice were divided into 2 subgroups, one displaying severe ventricular conduction defects (QRS interval>18 ms) and one a mild phenotype (QRS< or = 18 ms; QRS in wild-type littermates: 10-18 ms). Phenotypic difference persisted with aging. At 10 weeks, the Na+ channel blocker ajmaline prolonged QRS interval similarly in both groups of Scn5a(+/-) mice. In contrast, in old mice (>53 weeks), ajmaline effect was larger in the severely affected subgroup. These data matched the clinical observations on patients with SCN5A loss-of-function mutations with either severe or mild conduction defects. Ventricular tachycardia developed in 5/10 old severely affected Scn5a(+/-) mice but not in mildly affected ones. Correspondingly, symptomatic SCN5A-mutated Brugada patients had more severe conduction defects than asymptomatic patients. Old severely affected Scn5a(+/-) mice but not mildly affected ones showed extensive cardiac fibrosis. Mildly affected Scn5a(+/-) mice had similar Na(v)1.5 mRNA but higher Na(v)1.5 protein expression, and moderately larger I(Na) current than severely affected Scn5a(+/-) mice. As a consequence, action potential upstroke velocity was more decreased in severely affected Scn5a(+/-) mice than in mildly affected ones.
Scn5a(+/-) mice show similar phenotypic heterogeneity as SCN5A-mutated patients. In Scn5a(+/-) mice, phenotype severity correlates with wild-type Na(v)1.5 protein expression.
编码 Na(v)1.5 钠离子通道的 SCN5A 基因的功能丧失性突变与遗传性心脏传导缺陷和 Brugada 综合征相关,这两种疾病均表现出传导缺陷的可变表型外显率。我们在杂合子靶向敲除 Scn5a 的小鼠模型中研究了这种异质性的机制,并将我们的结果与 SCN5A 基因功能丧失性突变患者的结果进行了比较。
方法/主要发现:基于心电图,将 10 周龄的 Scn5a(+/-) 小鼠分为 2 个亚组,一个亚组表现出严重的心室传导缺陷(QRS 间隔>18ms),另一个亚组表现出轻度表型(QRS<或=18ms;野生型同窝仔鼠的 QRS 间隔:10-18ms)。随着年龄的增长,表型差异持续存在。在 10 周龄时,钠离子通道阻滞剂阿马林(ajmaline)在两组 Scn5a(+/-) 小鼠中均延长了 QRS 间隔。相比之下,在老年小鼠(>53 周龄)中,阿马林的作用在严重受影响的亚组中更大。这些数据与 SCN5A 基因功能丧失性突变患者的临床观察结果相匹配,这些患者既有严重的也有轻度的传导缺陷。5/10 只老年严重受影响的 Scn5a(+/-) 小鼠发生了室性心动过速,但轻度受影响的小鼠未发生。相应地,有症状的 SCN5A 突变 Brugada 患者的传导缺陷比无症状患者更严重。老年严重受影响的 Scn5a(+/-) 小鼠而非轻度受影响的小鼠表现出广泛的心脏纤维化。轻度受影响的 Scn5a(+/-) 小鼠的 Na(v)1.5 mRNA 相似,但 Na(v)1.5 蛋白表达更高,I(Na)电流也稍大,而严重受影响的 Scn5a(+/-) 小鼠则相反。因此,动作电位上升速度在严重受影响的 Scn5a(+/-) 小鼠中比在轻度受影响的小鼠中下降得更明显。
Scn5a(+/-) 小鼠表现出与 SCN5A 突变患者相似的表型异质性。在 Scn5a(+/-) 小鼠中,表型严重程度与野生型 Na(v)1.5 蛋白表达相关。